Functional analysis of hepatitis C virus E2 glycoproteins and virus-like particles reveals structural dissimilarities between different forms of E2

Journal of General Virology

Volumn 82, Issue 8, 2001, Pages 1877-1883

  Owsianka, A ^a   Clayton, R F ^a   Loomis Price, L D ^a   McKeating, J A ^a   Patel, A H ^a  

^a INSTITUTE OF VIROLOGY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CD81 ANTIGEN; HEPATITIS C VIRUS ENVELOPE GLYCOPROTEIN E1; HEPATITIS C VIRUS ENVELOPE GLYCOPROTEIN E2; LIGAND; MONOCLONAL ANTIBODY; UNCLASSIFIED DRUG; VIRUS GLYCOPROTEIN; VIRUS RECEPTOR;

AMINO ACID SEQUENCE; ANTIGEN BINDING; ARTICLE; COMPLEX FORMATION; CONTROLLED STUDY; HEPATITIS C VIRUS; IN VITRO STUDY; INSECT; MAMMAL CELL; NONHUMAN; PRIORITY JOURNAL; STRUCTURE ACTIVITY RELATION; VIRION; VIRUS PARTICLE;

ARACHNIDA; HEPATITIS C VIRUS; HEXAPODA; INSECTA; MAMMALIA; RNA VIRUSES;

EID: 0034894359     PISSN: 00221317     EISSN: None     Source Type: Journal    
DOI: 10.1099/0022-1317-82-8-1877     Document Type: Article

References (40)

1. Hepatitis C virus and other flaviviridae viruses enter cells via low density lipoprotein receptor
2. Hepatitis C virus structural proteins assemble into viruslike particles in insect cells
3. Hepatitis C virus-like particles synthesized in insect cells as a potential vaccine candidate
4. Isolation and characterization of human monoclonal antibodies against hepatitis C virus envelope glycoproteins
5. Hepatitis C virus glycoprotein E2 binding to CD81: The role of E1E2 cleavage and protein glycosylation in bioactivity
6. Involvement of endoplasmic reticulum chaperones in the folding of hepatitis C virus glycoproteins
7. Molecular virology of hepatitis C virus
8. A retention signal necessary and sufficient for endoplasmic reticulum localization maps to the transmembrane domain of hepatitis C virus glycoprotein E2
9. The transmembrane domain of hepatitis C virus glycoprotein E1 is a signal for static retention in the endoplasmic reticulum
10. Formation of native hepatitis C virus glycoprotein complexes
11. Folding, assembly and subcellular localization of hepatitis C virus glycoproteins
12. Formation and intracellular-localization of hepatitis-C virus envelope glycoprotein complexes expressed by recombinant vaccinia and sindbis viruses
13. Hepatitis C virus glycoprotein complex localization in the endoplasmic reticulum involves a determinant for retention and not retrieval
14. Prevention of hepatitis C virus infection in chimpanzees by hyperimmune serum against the hypervariable region 1 of the envelope 2 protein
15. The C-terminal region of the hepatitis C virus E1 glycoprotein confers localization within the endoplasmic reticulum
16. Characterization of hepatitis C virus E2 glycoprotein interaction with a putative cellular receptor, CD81
17. Functional characterization of intracellular and secreted forms of a truncated hepatitis C virus E2 glycoprotein
18. Characterization of modified hepatitis C virus E2 proteins expressed on the cell surface
19. Characterization of human monoclonal antibodies specific to the hepatitis C virus glycoprotein E2 with in vitro binding neutralization properties
20. Human monoclonal antibodies that inhibit binding of hepatitis C virus E2 protein to CD81 and recognize conserved conformational epitopes
21. Marked sequence diversity in the putative envelope proteins of hepatitis-C viruses
22. CD81 (TAPA-1): A molecule involved in signal transduction and cell adhesion in the immune system
23. Binding of hepatitis C virus E2 glycoprotein to CD81 does not correlate with species permissiveness to infection
24. Characterization of truncated forms of hepatitis C virus glycoproteins
25. Two hepatitis C virus glycoprotein E2 products with different C termini
26. Nucleotide-sequence and mutation-rate of the of the H-strain of hepatitis-C virus
27. Covalent interactions are not required to permit or stabilize the non-covalent association of hepatitis C virus glycoproteins E1 and E2
28. Construction and characterization of chimeric hepatitis C virus E2 glycoproteins: Analysis of regions critical for glycoprotein aggregation and CD81 binding
29. Structure-function analysis of hepatitis C virus envelope-CD81 binding
30. Binding of hepatitis C virus to CD81
31. Characterization of hepatitis-C virus envelope glycoprotein complexes expressed by recombinant vaccinia viruses
32. Flaviviridae: The viruses and their replication
33. A quantitative test to estimate neutralizing antibodies to the hepatitis C virus: Cytofluorimetric assessment of envelope glycoprotein 2 binding to target cells
34. Virus-encoded proteinases of the Flaviviridae
35. A hyperimmune serum against a synthetic peptide corresponding to the hypervariable region 1 of hepatitis C virus can prevent viral infection in cell cultures
36. Variable and hypervariable domains are found in the regions of HCV corresponding to the flavivirus envelope and Ns1 proteins and the pestivirus envelope glycoproteins
37. Characterization of hepatitis C virus (HCV) and HCV E2 interactions with CD81 and the low-density lipoprotein receptor
38. A model for the hepatitis C virus envelope glycoprotein E2
39. Transcripts from a single full-length cDNA clone of hepatitis C virus are infectious when directly transfected into the liver of a chimpanzee
40. Antibodies in human sera specific to hypervariable region 1 of hepatitis C virus can block viral attachment